Promoting societal resilience during the COVID-19 pandemic: a multi-country analysis of public health strategies
Main Article Content
Keywords
Covid-19, Resilience, Public Health, Vaccine hesitancy, Infodemic
Abstract
Background and aim: Enhancing public health communication during a global crisis is crucial to promote resilience. This study examines the influence of health communication in ten countries, analysing its positive and negative impact on society's behavior regarding the origin, symptoms, and prevention of SARS-CoV-2.
Methods: A comprehensive narrative analysis of available data was conducted to evaluate societal and resilience responses during the COVID-19 pandemic. The study consulted academic and grey literature, from February 1, 2020, to March 1, 2022, focusing on ten countries that exhibited heterogenous responses to pandemic, including EU (Italy, Denmark, Sweden, Spain, Portugal, Romania, France, and Germany) and non-EU (United Kingdom and Israel) countries.
Results: The stringency of policy responses varied between countries and over time, with some countries implementing strict lockdowns while others only issued recommendations. Vaccination campaign and the spread of less virulent variants of the virus has led most countries to lift most restrictions by April 2022. However, vaccine uptake and refusal remain complex issues influenced by social norms, cultural beliefs, access to information, and trust in government authorities. Social media played a significant role during the pandemic, but healthcare professionals’ active participation in addressing misinformation was lacking.
Conclusions: The COVID-19 pandemic highlighted the importance of Public Health in developing proper strategies and utilizing digitals tools to counteract infodemic and spread relevant information. Healthcare workers should improve their communication skills to face future epidemics and be trusted by the population. Social media and digital platforms should be studied and used effectively in times of emergency.
Downloads
References
2. Signorelli C. Public Health challenges in the post-pandemic era. The effects on life expectancy and health systems. Acta Biomed. 2023;94(Suppl.3): e2023112. Doi: 10.23750/abm.v94iS3.14575
3. ECDC. ECDC Covid-19 situation updates [Available from: https://www.ecdc.europa.eu/en/covid-19/situation-updates.
4. Mathieu E, Ritchie H, Rodés-Guirao L, et al. Coronavirus Pandemic (COVID-19), 2020 [Available from: https://
ourworldindata.org/coronavirus#explore-the-global-situation.
5. Wikipedia. Flattening the curve, 2020 [updated 29/01/2023. Available from: https://en.wikipedia.org/wiki
/Flattening_the_curve.
6. Boumans M. Flattening the curve is flattening the complexity of covid-19. Hist Philos Life Sci. 2021;43(1):18. doi: 10.1007/s40656-021-00374-x
7. Barclay E SD, Animashaun C. Coronavirus USA chart: Flattening the curve and “raising the line” of hospital capacity, Vox. 2020 [updated 7/04/2020. Available from: https://www.vox.com/2020/4/7/21201260/coronavirus-usa-chart-mask-shortage-ventilators-flatten-the-curve.
8. ECDC. Non-pharmaceutical interventions against COVID-19, 2020 [updated 7/03/2023. Available from: https://www.ecdc.europa.eu/en/covid-19/prevention-and
-control/non-pharmaceutical-interventions.
9. Silva C, Cruz C, Torres DFM et al. Optimal control of the COVID-19 pandemic: controlled sanitary deconfinement in Portugal. Sci Rep. 2021;11(1):3451. doi: 10.1038/s41598-021-83075-6
10. Royo S. Responding to COVID-19: The Case of Spain. Eur Policy Anal. 2020;6(2):180-90. doi: 10.1002/epa2.1099
11. Signorelli C, Odone A, Gianfredi V, et al. COVID-19 mortality rate in nine high-income metropolitan regions. Acta Biomed. 2020;91(9-S):7-18. doi: 10.23750/abm.v91i9-S.10134
12. Signorelli C, Odone A, Gianfredi V, et al. The spread of COVID-19 in six western metropolitan regions: a false myth on the excess of mortality in Lombardy and the defense of the city of Milan. Acta Biomed. 2020;91(2):23-30. doi: 10.23750/abm.v91i2.9600
13. Ministry of Health I. Gazzetta Ufficiale. Available from: https://www.gazzettaufficiale.it/eli/id/2020
/02/23/20A01228/sg.
14. Cereda D, Manica M, Tirani M, et al. The early phase of the COVID-19 epidemic in Lombardy, Italy. Epidemics. 2021;37. doi: 10.1016/j.epidem.2021.100528
15. Mattei A. Measures implemented in Italy to fight the pandemic. Rev droit comparé du Trav la sécurité Soc. 2020:194-7. doi: 10.4000/rdctss.919
16. Signorelli C, Scognamiglio T, Odone A. COVID-19 in Italy: impact of containment measures and prevalence estimates of infection in the general population. Acta Biomed. 2020;91(3-S):175-9. doi: 10.23750/abm.v91i3-S.9511
17. Or Z, Gandré C, Durand Zaleski I, Steffen M. France’s response to the Covid-19 pandemic: between a rock and a hard place. Health Econ Policy Law. 2021;17(1):14-26. doi: 10.1017/S1744133121000165
18. Last M. The first wave of COVID-19 in Israel-Initial analysis of publicly available data. PLoS One. 2020;15(10):e0240393. doi:10.1371/journal.pone.0240393
19. MoH I. Available online: The Novel Coronavirus [Available from: https://govextra.gov.il/ministry-of-health/corona
/corona-virus-en/.
20. Waitzberg R DN, Leibner G, Penn N, Brammli-Greenberg S. Israel’s response to the COVID-19 pandemic: Tailoring measures for vulnerable cultural minority populations. Int J Equity Health. 2020;19(1):71. doi: 10.1186/s12939-020-01191-7
21. Lu G, Razum O, Jahn A, et al. COVID-19 in Germany and China: mitigation versus elimination strategy. Glob Health Action. 2021;14(1). doi: 10.1080/16549716.2021.1875601
22. HouseOfCommonsLibrary. Coronavirus: A history of English lockdown laws. Available online: [Available from: https://commonslibrary.parliament.uk/research-briefings
/cbp-9068/.
23. GOV.UK. Coronavirus (COVID-19): guidance and support [Available from: https://www.gov.uk/coronavirus.
24. Goverment of Denmark. Rules and regulations [Available from: https://en.coronasmitte.dk/rules-and-regulations
25. Krisinformation.se. Official information about Covid-19 2020 [Available from: https://www.krisinformation.se
/en/hazards-and-risks/disasters-and-incidents/2020/official-information-on-the-new-coronavirus.
26. Ministry of Foreign Affairs, Government of Romania. Conditions to enter Romania. [Available from: https://www.mae.ro/en/node/30320.
27. Government of Spain. Spain Travel Health [Available from: https://www.spth.gob.es/.
28. EuropeanUnion. Re-open EU 2021 [Available from: https://reopen.europa.eu/it.
29. EuropeanCommission. EU Digital COVID Certificate 2021 [Available from: https://ec.europa.eu/info/live-work
-travel-eu/coronavirus-response/safe-covid-19-vaccines
-europeans/eu-digital-covid-certificate_en.
30. EuropeanCommission. Travel during the coronavirus pandemic | [Available from: https://ec.europa.eu/info
/live-work-travel-eu/coronavirus-response/travel
-during-coronavirus-pandemic_en.
31. OurWorldInData. What is the COVID-19 Stringency Index? [Available from: https://ourworldindata.org/metrics
-explained-covid19-stringency-index.
32. OurWorldInData. COVID-19: Stringency Index [Available from: https://ourworldindata.org/covid-stringency-index.
33. European Medicines Agency E. COVID-19 vaccines: authorised | [Available from: https://www.ema.europa.eu
/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-authorised.
34. European Center for Disease Control and Prevention E. COVID-19 Vaccine Tracker | [Available from: https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab.
35. GOV.UK. One year anniversary of UK deploying Oxford-AstraZeneca vaccine [Available from: https://www.gov.uk
/government/news/one-year-anniversary-of-uk-deploying-oxford-astrazeneca-vaccine.
36. BBC News. Covid-19 vaccine: First person receives Pfizer jab in UK - [Available from: https://www.bbc.com/news
/uk-55227325.
37. Burki TK. Fourth dose of COVID-19 vaccines in Israel. Lancet Respir Med. 2022;10(19):e19. doi: 10.1016/S2213-2600(22)00010-8
38. Portugal has one of the top vaccination rates but isn’t taking chances with omicron : NPR [Available from: https://www
.npr.org/2021/12/15/1063830104/portugal-covid-vaccines-omicron-variant?t=1652969866501.
39. Society | EL PAÍS. Covid-19: In just eight months, Spain hits target of fully vaccinating 70% of population | [Available from: https://english.elpais.com/society/2021-09-01/in-just-eight-months-spain-hits-target-of-fully-vaccinating-70-of-population.html
40. OurWorldInData. Coronavirus (COVID-19) Vaccinations - [Available from: https://ourworldindata.org/covid
-vaccinations?country=OWID_WRL.
41. European Center for Disease Control and Prevention E. Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA [Available from: https://www.ecdc.europa.eu/en/publications
-data/overview-implementation-covid-19-vaccination-strategies-and-deployment-plans.
42. Antonini M, Eid MA, Falkenbach M, et al. An analysis of the COVID-19 vaccination campaigns in France, Israel, Italy and Spain and their impact on health and economic outcomes. Heal Policy Technol. 2022;11(2):100594. doi: 10.1016/j.hlpt.2021.100594.
43. Euronews. Why did Romania’s vaccination campaign derail after such a good start?. 2021 [Available from: https://www
.euronews.com/my-europe/2021/06/08/why-did-romania-s-vaccination-campaign-derail-after-a-successful-start.
44. Robert Koch Institut, RKI. National COVID-19 Vaccination Strategy: Strategy to Introduce and Evaluate a Vaccine against Sars-CoV-2 in Germany. 2020 [Available from: https://www.rki.de/EN/Content/infections/epidemiology
/outbreaks/COVID-19/COVID-19_Vaccination_Strategy.html.
45. Spetz M, Lundberg L, Nwaru C, et al. The social patterning of Covid-19 vaccine uptake in older adults: A register-based cross-sectional study in Sweden. Lancet Reg Heal - Eur 2022;15(5). doi: 10.1016/j.lanepe.2022.100331
46. French J DS, Evans W, Obregon R. Key Guidelines in Developing a Pre-Emptive COVID-19 Vaccination Uptake Promotion Strategy. Int J Environ Res Public Health. 2020;17:1-14. doi: 10.3390/ijerph17165893
47. Assoumou SA, Peterson A, Ginman E, et al. Addressing Inequities in SARS-CoV-2 Vaccine Uptake: The Boston Medical Center Health System Experience. Ann Intern Med 2022;175(6):879-84. doi: 10.7326/M22-0028
48. Montaigne I. Europe versus Coronavirus - Putting
the Danish Model to the Test | [Available from: https://www.institutmontaigne.org/en/blog/europe
-versus-coronavirus-putting-danish-model-test.
49. Government of Denmark. Covid-19 status. Available from: https://en
.coronasmitte.dk/general-information/vaccination. [accessed 28 August 2023].
50. Odone A, Signorelli C. When vaccine hesitancy makes headlines. Vaccine. 2017;35(9):1209-10. doi: 10.1016/j.vaccine.2015.11.051
51. Gentile L, Cuda, A., Dallagiacoma, G. et al. Opinion, knowledge and attitude of public health residents towards the new mandatory vaccination law in Italy. J Public Health (Berl). 2021;29:659-69. doi: 10.1007/s10389-019-01171-4
52. Boness CL, Nelson M, Douaihy AB. Motivational Interviewing Strategies for Addressing COVID-19 Vaccine Hesitancy. J Am Board Fam Med. 2022(35):420-6. doi: 10.3122/jabfm.2022.02.210327
53. Campos-Mercade P, Meier AN, Schneider FH, Meier S,
Pope D, Wengström E. Monetary incentives increase COVID-19 vaccinations. Science. 2021(374):879-82. doi: 10.1126/science.abm047
54. OECD. Enhancing public trust in COVID-19 vaccination: The role of governments - [Available from: https://read.oecd-ilibrary.org/view/?ref=1094_1094290-a0n03doefx&title=Enhancing-public-trust-in-COVID-19-vaccination-The-role-of-governments.
55. JP M. Media Consumption in the Age of COVID-19 [Available from: https://www.jpmorgan.com/insights/research
/media-consumption.
56. Mascherini M NS. Social media use and vaccine hesitancy in the European Union. Vaccine. 2022;40:2215-25. doi: 10.1016/j.vaccine.2022.02.059
57. Biasio LR, Corsello G, Costantino C, et al. Communication about vaccination: A shared responsibility. Human Vaccines & Immunotherapeutics. 2016(11):2984-7. doi:10.1080/21645515.2016.1198456
Article Sidebar
Article Details
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
